Press Releases

TLC to Present at Upcoming Virtual Investor Conferences


TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that the Company’s management team will be presenting at the following virtual investor conferences:

HC Wainwright & Co 23rd Annual Global Investment Conference
September 13-15, 2021
Presentation will be available on-demand during the conference  

2021 Cantor Virtual Global Healthcare Conference
September 27-30, 2021
Presentation: 10:00am ET, Monday, September 27, 2021

The management team will also be participating in one-on-one meetings during the conference. The corporate presentation will be available on the TLC website at in the Investors section, under News & Events.